menu
    • menu

    Company profile for Xencor

    NEW Drugs in Dev: 27
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xencor is also discovering biologics products that improve the performance of old antibody drugs, known as biosuperiors, to benefit patients, ease compliance and help reduce costs. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug fea...
    Xencor is also discovering biologics products that improve the performance of old antibody drugs, known as biosuperiors, to benefit patients, ease compliance and help reduce costs. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XencorUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    111 West Lemon Avenue Monrovia, CA 91016
    Telephone
    Telephone
    (626) 305-5900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://xencor.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xencor
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/xencor?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xencor Spotlights 2026 Pipeline Goals
    Xencor Spotlights 2026 Pipeline Goals

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108654667/en/Xencor-Highlights-Corporate-Priorities-and-2026-Pipeline-Milestones

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Xencor Extends US Patent Term For Specific Xtend Antibodies
    Xencor Extends US Patent Term For Specific Xtend Antibodies

    09 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209345770/en/Xencor-Announces-Extension-of-U.S.-Patent-Term-on-Certain-Xtend-Antibodies

    BUSINESSWIRE
    09 Dec 2025
    Share Share
    Xencor To Participate At Upcoming Investor Conferences
    Xencor To Participate At Upcoming Investor Conferences

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110946225/en/Xencor-to-Participate-at-Upcoming-Investor-Conferences

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Xencor Reports Third Quarter 2025 Financial Results
    Xencor Reports Third Quarter 2025 Financial Results

    05 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251105353167/en/Xencor-Reports-Third-Quarter-2025-Financial-Results

    BUSINESS WIRE
    05 Nov 2025
    Share Share
    Xencor Unveils Early Data For Xmab819 In Clear Cell Renal Cell
    Xencor Unveils Early Data For Xmab819 In Clear Cell Renal Cell

    24 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251024632665/en/Xencor-Presents-Initial-Data-for-XmAb819-a-First-in-class-ENPP3-x-CD3-Bispecific-T-Cell-Engager-in-Development-for-Clear-Cell-Renal-Cell-Carcinoma

    BUSINESSWIRE
    24 Oct 2025
    Share Share
    Xencor to Discuss Ph1 XmAb819 Results in Renal Cell Carcinoma
    Xencor to Discuss Ph1 XmAb819 Results in Renal Cell Carcinoma

    21 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020540696/en/Xencor-to-Host-Webcast-and-Conference-Call-to-Discuss-Initial-Results-from-the-Ongoing-Phase-1-Dose-Escalation-Study-of-XmAb819-in-Advanced-Clear-Cell-Renal-Cell-Carcinoma

    BUSINESSWIRE
    21 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search